Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05QJK
|
||||
| Former ID |
DNC003777
|
||||
| Drug Name |
Benzyl-[2-(1H-indazol-4-yloxy)-ethyl]-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [525599] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H17N3O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CNCCOC2=CC=CC3=C2C=NN3
|
||||
| InChI |
1S/C16H17N3O/c1-2-5-13(6-3-1)11-17-9-10-20-16-8-4-7-15-14(16)12-18-19-15/h1-8,12,17H,9-11H2,(H,18,19)
|
||||
| InChIKey |
WYGBVOBBNUHWLX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(3) dopamine receptor | Target Info | Inhibitor | [525599] | |
| D(4) dopamine receptor | Target Info | Inhibitor | [525599] | ||
| D(2) dopamine receptor | Target Info | Inhibitor | [525599] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Nicotine pharmacodynamics pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.